IRIS PHARMA

Not just an ophthalmology-focused CRO, Iris Pharma helps clients around the world navigate every stage of the drug and device development process and delivers customized solutions for: • Assessing possible therapeutic effect in ocular diseases • Adding value to promising drug candidates or medical devices • Designing development plans and preclinical packages and carrying out studies to proceed with confidence from bench to bedside • Providing the comprehensive clinical development services you need, from First-in-Human through Phase IV and Post-marketing follow-through We accompany start-up companies, biotechnology companies, large pharmaceutical companies, pharmaceutical labs, universities, research organizations and consultants in their ophthalmology projects. Our assets: • 32 years of experience in the field of ophthalmology research • All ophthalmic indications mastered • 70+ FDA, PMDA & EMA new ocular drug approvals and ophthalmic medical device marketing authorizations • State-of-the-art medical and scientific equipment • Highly specialized and qualified staff • Statement of compliance with GLP and GCLP • Adherence to all trial-related requirements (ICH-GCP) • French research tax credit accreditation (CIR)